1	An	an	_	_	_	_	_	_	_
2	essential	essential	_	_	_	_	_	_	_
3	role	role	_	_	_	_	_	_	_
4	for	for	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	CD34(+)	cd34(+)	_	_	_	_	_	_	_
9	bone	bone	_	_	_	_	_	_	_
10	marrow	marrow	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	survival	survival	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	important	important	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	T-cell	t-cell	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	B-cell	b-cell	_	_	_	_	_	_	_
14	maturation	maturation	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
19	virus	virus	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	plays	play	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	role	role	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	alternatively	alternatively	_	_	_	_	_	_	_
27	mediating	mediate	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	protecting	protect	_	_	_	_	_	_	_
30	against	against	_	_	_	_	_	_	_
31	apoptosis	apoptosis	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	variety	variety	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	cell	cell	_	_	_	_	_	_	_
37	types	type	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	role	role	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	CD34(+)	cd34(+)	_	_	_	_	_	_	_
10	bone	bone	_	_	_	_	_	_	_
11	marrow	marrow	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	has	have	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	been	be	_	_	_	_	_	_	_
16	described	describe	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	provide	provide	_	_	_	_	_	_	_
3	evidence	evidence	_	_	_	_	_	_	_
4	here	here	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	virtually	virtually	_	_	_	_	_	_	_
7	all	all	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	CD34(+)	cd34(+)	_	_	_	_	_	_	_
10	bone	bone	_	_	_	_	_	_	_
11	marrow	marrow	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	express	express	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	can	can	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	exposure	exposure	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	phorbol	phorbol	_	_	_	_	_	_	_
23	12-myristate	12-myristate	_	_	_	_	_	_	_
24	13-acetate	13-acetate	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	variety	variety	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	cytokines	cytokine	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	eg	eg	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	tumor	tumor	_	_	_	_	_	_	_
34	necrosis	necrosis	_	_	_	_	_	_	_
35	factor	factor	_	_	_	_	_	_	_
36	alpha	alpha	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	interleukin-3	interleukin-3	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
42	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
43	factor	factor	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	be	be	_	_	_	_	_	_	_
10	required	require	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	CD34(+)	cd34(+)	_	_	_	_	_	_	_
14	bone	bone	_	_	_	_	_	_	_
15	marrow	marrow	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	clonogenic	clonogenic	_	_	_	_	_	_	_
18	function	function	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	survival	survival	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	offer	offer	_	_	_	_	_	_	_
4	insight	insight	_	_	_	_	_	_	_
5	into	into	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	new	new	_	_	_	_	_	_	_
8	role	role	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	maintaining	maintain	_	_	_	_	_	_	_
13	survival	survival	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	function	function	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	hematopoietic	hematopoietic	_	_	_	_	_	_	_
18	stem	stem	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	progenitor	progenitor	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	suggest	suggest	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	proposed	propose	_	_	_	_	_	_	_
26	strategies	strategy	_	_	_	_	_	_	_
27	involving	involve	_	_	_	_	_	_	_
28	inhibition	inhibition	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
31	activation	activation	_	_	_	_	_	_	_
32	as	as	_	_	_	_	_	_	_
33	an	an	_	_	_	_	_	_	_
34	adjunct	adjunct	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	cancer	cancer	_	_	_	_	_	_	_
37	chemotherapy	chemotherapy	_	_	_	_	_	_	_
38	should	should	_	_	_	_	_	_	_
39	be	be	_	_	_	_	_	_	_
40	approached	approach	_	_	_	_	_	_	_
41	with	with	_	_	_	_	_	_	_
42	caution	caution	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

